Racial Differences in Testicular Cancer in the United States: Descriptive Epidemiology

Overview

Journal BMC Cancer

Publisher Biomed Central

Specialty Oncology

Date 2020 Apr 8

PMID 32252689

Citations 20

Authors

Yang Li

Qi Lu

Yu Wang

Shuangge Ma

Affiliations

Soon will be listed here.

Abstract

Background: Testicular cancer (TC) is the most common malignancy in young adult men, and in many countries the incidence rates of testicular cancer have been increasing since the middle of the twentieth century. Since disease presentation and tumor progression patterns are often heterogeneous across racial groups, there may be important racial differences in recent TC trends.

Methods: In this study, Surveillance, Epidemiology, and End Results (SEER) data on TC patients diagnosed between 1973 and 2015 were analyzed, including the following racial/ethnic groups: non-Hispanic whites (NHW), Hispanic whites (HW), blacks, and Asians and Pacific Islanders (API). Patient characteristics, age-adjusted incidence rates, and survival were compared across racial groups. A multivariate Cox model was used to analyze the survival data of TC patients, in order to evaluate racial differences across several relevant factors, including marital status, age group, histologic type, treatment, stage, and tumor location.

Results: NHWs had the highest incidence rates, followed by blacks, HWs, and APIs. There were significant survival differences among the racial groups, with NHWs having the highest survival rates and blacks having the lowest.

Conclusion: An analysis of SEER data showed that racial differences existed among TC patients in the United States with respect to patient characteristics, incidence, and survival. The results can be useful to stakeholders interested in reducing the burden of TC morbidity and mortality.

Citing Articles

A review of the carcinogenic potential of human papillomavirus (HPV) in urological cancers.

Zolfi E, Khaleghi Mehr F, Emtiazi N, Moradi Y Virol J. 2025; 22(1):53.

PMID: 40022189 PMC: 11871667. DOI: 10.1186/s12985-025-02682-1.

Use of inpatient palliative care in metastatic testicular cancer patients undergoing critical care therapy: insights from the national inpatient sample.

Garcia C, Incesu R, Barletta F, Morra S, Scheipner L, Baudo A Sci Rep. 2025; 15(1):967.

PMID: 39762392 PMC: 11704327. DOI: 10.1038/s41598-024-83545-7.

Trends in incidence and demographics of testicular cancer in California, 2000-2020.

Benjamin D, Shrestha A, Fellman D, Kalebasty A BJUI Compass. 2025; 5(12):1249-1251.

PMID: 39744080 PMC: 11685165. DOI: 10.1002/bco2.451.

Comparative analysis of testicular and nontesticular choriocarcinoma: a population-based study.

Alshwayyat S, Soudi M, Qaddoura M, Alshwayyat T, Ababneh O, Hanifa H Ann Med Surg (Lond). 2024; 86(12):6951-6959.

PMID: 39649900 PMC: 11623855. DOI: 10.1097/MS9.0000000000002702.

Striving for Equity: Examining Health Disparities in Urologic Oncology.

Puri D, Pandit K, Choi N, Rose B, McKay R, Bagrodia A Cancers (Basel). 2024; 16(21).

PMID: 39518000 PMC: 11544812. DOI: 10.3390/cancers16213559.

References

Brown L, Pottern L, Hoover R . Prenatal and perinatal risk factors for testicular cancer. Cancer Res. 1986; 46(9):4812-6. View

Rosen A, Jayram G, Drazer M, Eggener S . Global trends in testicular cancer incidence and mortality. Eur Urol. 2011; 60(2):374-9. DOI: 10.1016/j.eururo.2011.05.004. View

Bray F, Ferlay J, Devesa S, McGlynn K, Moller H . Interpreting the international trends in testicular seminoma and nonseminoma incidence. Nat Clin Pract Urol. 2006; 3(10):532-43. DOI: 10.1038/ncpuro0606. View

Bridges P, Sharifi R, Razzaq A, Guinan P . Decreased survival of black Americans with testicular cancer. J Urol. 1998; 159(4):1221-3. View

Nguyen M, Ellison L . Testicular cancer patterns in Asian-American males: an opportunity for public health education to impact outcomes. Urology. 2005; 66(3):606-9. DOI: 10.1016/j.urology.2005.03.069. View

Siegel R, Miller K, Jemal A . Cancer statistics, 2019. CA Cancer J Clin. 2019; 69(1):7-34. DOI: 10.3322/caac.21551. View

Brown L, Pottern L, Hoover R, Devesa S, Aselton P, Flannery J . Testicular cancer in the United States: trends in incidence and mortality. Int J Epidemiol. 1986; 15(2):164-70. DOI: 10.1093/ije/15.2.164. View

Cavalli F, Monfardini S, Pizzocaro G . Report on the International Workshop on Staging and Treatment of Testicular Cancer. Eur J Cancer (1965). 1980; 16(10):1367-72. DOI: 10.1016/0014-2964(80)90296-0. View

Moul J, Schanne F, Thompson I, Frazier H, Peretsman S, WETTLAUFER J . Testicular cancer in blacks. A multicenter experience. Cancer. 1994; 73(2):388-93. DOI: 10.1002/1097-0142(19940115)73:2<388::aid-cncr2820730225>3.0.co;2-q. View

10.

Ross R, McCurtis J, Henderson B, Menck H, Mack T, Martin S . Descriptive epidemiology of testicular and prostatic cancer in Los Angeles. Br J Cancer. 1979; 39(3):284-92. PMC: 2009877. DOI: 10.1038/bjc.1979.53. View

11.

Willis G, HAJDU S . Histologically benign teratoid metastasis of testicular embryonal carcinoma: report of five cases. Am J Clin Pathol. 1973; 59(3):338-43. DOI: 10.1093/ajcp/59.3.338. View

12.

Mayberry R, Mili F, Ofili E . Racial and ethnic differences in access to medical care. Med Care Res Rev. 2000; 57 Suppl 1:108-45. DOI: 10.1177/1077558700057001S06. View

13.

Gajendran V, Nguyen M, Ellison L . Testicular cancer patterns in African-American men. Urology. 2005; 66(3):602-5. DOI: 10.1016/j.urology.2005.03.071. View

14.

McGlynn K, Devesa S, Graubard B, Castle P . Increasing incidence of testicular germ cell tumors among black men in the United States. J Clin Oncol. 2005; 23(24):5757-61. DOI: 10.1200/JCO.2005.08.227. View

15.

Fujikawa K, Matsui Y, Oka H, Fukuzawa S, Sasaki M, Takeuchi H . Prognosis of primary testicular seminoma: a report on 57 new cases. Cancer Res. 2000; 60(8):2152-4. View

16.

Bray F, Klint A, Gislum M, Hakulinen T, Engholm G, Tryggvadottir L . Trends in survival of patients diagnosed with male genital cancers in the Nordic countries 1964-2003 followed up until the end of 2006. Acta Oncol. 2010; 49(5):644-54. DOI: 10.3109/02841860903575315. View

17.

Pettersson A, Richiardi L, Nordenskjold A, Kaijser M, Akre O . Age at surgery for undescended testis and risk of testicular cancer. N Engl J Med. 2007; 356(18):1835-41. DOI: 10.1056/NEJMoa067588. View

18.

Atkin N, Baker M . Specific chromosome change, i(12p), in testicular tumours?. Lancet. 1982; 2(8311):1349. DOI: 10.1016/s0140-6736(82)91557-4. View

19.

Wang Y, Zhao Y, Ma S . Racial differences in six major subtypes of melanoma: descriptive epidemiology. BMC Cancer. 2016; 16:691. PMC: 5004333. DOI: 10.1186/s12885-016-2747-6. View

20.

Liu S, Semenciw R, Waters C, Wen S, Mery L, Mao Y . Clues to the aetiological heterogeneity of testicular seminomas and non-seminomas: time trends and age-period-cohort effects. Int J Epidemiol. 2000; 29(5):826-31. DOI: 10.1093/ije/29.5.826. View